Investor-State Dispute Settlement Between Developed Countries: Reflections on the Australia-United States Free Trade Agreement

Developing Countries and General Agreement on Tariffs and Trade/World Trade Organization Dispute Settlement

It has long been observed that developing countries made scant use of dispute settlement under the General Agreement on Tariffs and Trade (GATT). Less clear are the reasons for this. Most observers insist that the various GATT reforms that were intended to help developing countries failed to insulate them from the “power politics” of the system (Kuruvila, 1997). Not surprisingly, many of these ...

Trade brief on . . . The WTO Dispute Settlement

Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?

The Australia-United States Free Trade Agreement (AUSFTA) contains major concessions to the US pharmaceutical industry that may undermine the egalitarian principles and operation of the Pharmaceutical Benefits Scheme (PBS) and substantially increase the costs of medicinal drugs to Australian consumers. AUSFTA's approach to the PBS excessively emphasises the need to reward manufacturers of "inno...

Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme.

Robbery under arms: Copyright law and the Australia - United States Free Trade Agreement